Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Immunovant Inc (NASDAQ: IMVT) closed at $19.42 in the last session, up 5.03% from day before closing price of $18.49. In other words, the price has increased by $5.03 from its previous closing price. On the day, 0.87 million shares were traded.
Ratios:
We take a closer look at IMVT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 19 ’25 when Macias William L. sold 2,055 shares for $20.86 per share. The transaction valued at 42,867 led to the insider holds 357,353 shares of the business.
Barnett Eva Renee sold 2,814 shares of IMVT for $58,700 on Feb 19 ’25. The Chief Financial Officer now owns 321,952 shares after completing the transaction at $20.86 per share. On Feb 19 ’25, another insider, Salzmann Peter, who serves as the Chief Executive Officer of the company, sold 15,439 shares for $20.86 each. As a result, the insider received 322,058 and left with 948,786 shares of the company.
Stock Price History:
Over the past 52 weeks, IMVT has reached a high of $35.97, while it has fallen to a 52-week low of $17.65. The 50-Day Moving Average of the stock is -12.81%, while the 200-Day Moving Average is calculated to be -28.48%.
Shares Statistics:
A total of 147.20M shares are outstanding, with a floating share count of 69.35M. Insiders hold about 59.17% of the company’s shares, while institutions hold 47.39% stake in the company.
